"Iris Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.
| Descriptor ID |
D015811
|
| MeSH Number(s) |
C04.588.364.978.400 C11.319.494.400 C11.941.375.375 C11.941.855.400
|
| Concept/Terms |
Iris Neoplasms- Iris Neoplasms
- Neoplasms, Iris
- Iris Neoplasm
- Neoplasm, Iris
|
Below are MeSH descriptors whose meaning is more general than "Iris Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Iris Neoplasms".
This graph shows the total number of publications written about "Iris Neoplasms" by people in this website by year, and whether "Iris Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 0 | 3 |
| 2002 | 4 | 0 | 4 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 5 | 0 | 5 |
| 2012 | 2 | 0 | 2 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 1 | 4 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Iris Neoplasms" by people in Profiles.
-
Dockery PW, DeSimone JD, Liu CK, Achuck K, Hamburger J, Bas Z, Shields CL. Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches. Can J Ophthalmol. 2024 Oct; 59(5):329-334.
-
Singla K, Vempuluru VS, Ehya H, Shields CL. Iridociliary metastasis from cryptic cutaneous melanoma simulating primary uveal melanoma. Can J Ophthalmol. 2024 Aug; 59(4):e399-e401.
-
Card KR, Barke MR, Shields JA. Iris Melanocytoma with Minimal Change over 50 Years. Ophthalmology. 2023 Dec; 130(12):1350.
-
Shukla AG, Vaidya S, Yaghy A, Di Nicola M, Kaliki S, Fulco E, Myers JS, Shields JA, Shields CL. Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre. Eye (Lond). 2023 04; 37(5):938-946.
-
Bas Z, Yaghy A, Shields CL. Iris melanoma with neovascularization in sector melanocytosis controlled with 125I plaque radiotherapy and bevacizumab. J Fr Ophtalmol. 2021 May; 44(5):738-739.
-
Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma. Eye (Lond). 2021 10; 35(10):2754-2762.
-
Mudhar HS, Milman T, Eagle RC, Sanderson T, Pheasey L, Paine S, Salvi S, Rennie IG, Rundle P, Shields CL, Shields JA. Usefulness of PAX8 Immunohistochemistry in?Adult Intraocular Tumor Diagnosis. Ophthalmology. 2021 05; 128(5):765-778.
-
Ang SM, Dalvin LA, Emrich J, Komarnicky L, Shields JA, Shields CL. Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center. Asia Pac J Ophthalmol (Phila). 2019 Jan-Feb; 8(1):30-35.
-
Shields JA, Shields CL, Lally SE, Milman T, Eagle RC. Iris Melanoma in a Child Simulating Juvenile Xanthogranuloma. Middle East Afr J Ophthalmol. 2018 Apr-Jun; 25(2):115-117.
-
Shields CL, Di Nicola M, Bekerman VP, Kaliki S, Alarcon C, Fulco E, Shields JA. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients. Ophthalmology. 2018 06; 125(6):913-923.